390 related articles for article (PubMed ID: 17461423)
21. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.
Segura MM; Kamen A; Trudel P; Garnier A
Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800
[TBL] [Abstract][Full Text] [Related]
22. Transient gene expression in suspension HEK-293 cells: application to large-scale protein production.
Baldi L; Muller N; Picasso S; Jacquet R; Girard P; Thanh HP; Derow E; Wurm FM
Biotechnol Prog; 2005; 21(1):148-53. PubMed ID: 15903252
[TBL] [Abstract][Full Text] [Related]
23. Exploiting heparin-binding properties of MoMLV-based retroviral vectors for affinity chromatography.
Segura MM; Kamen A; Lavoie MC; Garnier A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):124-31. PubMed ID: 16971193
[TBL] [Abstract][Full Text] [Related]
24. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum.
DePolo NJ; Reed JD; Sheridan PL; Townsend K; Sauter SL; Jolly DJ; Dubensky TW
Mol Ther; 2000 Sep; 2(3):218-22. PubMed ID: 10985952
[TBL] [Abstract][Full Text] [Related]
25. Scaleable production of adenoviral vectors by transfection of adherent PER.C6 cells.
Subramanian S; Kim JJ; Harding F; Altaras GM; Aunins JG; Zhou W
Biotechnol Prog; 2007; 23(5):1210-7. PubMed ID: 17715941
[TBL] [Abstract][Full Text] [Related]
26. Optimization of transfection mediated by calcium phosphate for plasmid rAAV-LacZ (recombinant adeno-associated virus-beta-galactosidase reporter gene) production in suspension-cultured HEK-293 (human embryonic kidney 293) cells.
Feng L; Guo M; Zhang S; Chu J; Zhuang Y; Zhang S
Biotechnol Appl Biochem; 2007 Feb; 46(Pt 2):127-35. PubMed ID: 17052245
[TBL] [Abstract][Full Text] [Related]
27. Optimized large-scale production of high titer lentivirus vector pseudotypes.
Sena-Esteves M; Tebbets JC; Steffens S; Crombleholme T; Flake AW
J Virol Methods; 2004 Dec; 122(2):131-9. PubMed ID: 15542136
[TBL] [Abstract][Full Text] [Related]
28. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
[TBL] [Abstract][Full Text] [Related]
29. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture.
Broussau S; Jabbour N; Lachapelle G; Durocher Y; Tom R; Transfiguracion J; Gilbert R; Massie B
Mol Ther; 2008 Mar; 16(3):500-7. PubMed ID: 18180776
[TBL] [Abstract][Full Text] [Related]
30. High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells.
Hildinger M; Baldi L; Stettler M; Wurm FM
Biotechnol Lett; 2007 Nov; 29(11):1713-21. PubMed ID: 17636388
[TBL] [Abstract][Full Text] [Related]
31. Large-scale production means for the manufacturing of lentiviral vectors.
Schweizer M; Merten OW
Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245
[TBL] [Abstract][Full Text] [Related]
32. Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines.
Manceur AP; Kim H; Misic V; Andreev N; Dorion-Thibaudeau J; Lanthier S; Bernier A; Tremblay S; Gélinas AM; Broussau S; Gilbert R; Ansorge S
Hum Gene Ther Methods; 2017 Dec; 28(6):330-339. PubMed ID: 28826344
[TBL] [Abstract][Full Text] [Related]
33. Replicative fidelity of lentiviral vectors produced by transient transfection.
Laakso MM; Sutton RE
Virology; 2006 May; 348(2):406-17. PubMed ID: 16469344
[TBL] [Abstract][Full Text] [Related]
34. Generation of lentiviral vectors for use in skeletal muscle research.
Pichavant C; Tremblay JP
Methods Mol Biol; 2012; 798():285-95. PubMed ID: 22130843
[TBL] [Abstract][Full Text] [Related]
35. Generation of stable suspension producer cell lines for serum-free lentivirus production.
Klimpel M; Terrao M; Bräuer M; Dersch H; Biserni M; Melo Do Nascimento L; Schwingal S; Vogel JE; Ferlemann C; Brandt T; Lal NI; Bridgeman K; Petzke A; McDwyer E; Lim JL; Oh S; Brumatti G; Garcia Minambres A; Otte E; Noll T; Pirzas V; Laux H
Biotechnol J; 2024 May; 19(5):e2400090. PubMed ID: 38719592
[TBL] [Abstract][Full Text] [Related]
36. Generation of lentivirus vectors using recombinant baculoviruses.
Lesch HP; Turpeinen S; Niskanen EA; Mähönen AJ; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2008 Sep; 15(18):1280-6. PubMed ID: 18463689
[TBL] [Abstract][Full Text] [Related]
37. Improvement in the suspension-culture production of recombinant adeno-associated virus-LacZ in HEK-293 cells using polyethyleneimine-DNA complexes in combination with hypothermic treatment.
Feng L; Guo M; Zhang S; Chu J; Zhuang Y; Zhang S
Biotechnol Appl Biochem; 2008 Jun; 50(Pt 2):121-32. PubMed ID: 17880281
[TBL] [Abstract][Full Text] [Related]
38. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
39. Comparison of transfection conditions for a lentivirus vector produced in large volumes.
Karolewski BA; Watson DJ; Parente MK; Wolfe JH
Hum Gene Ther; 2003 Sep; 14(14):1287-96. PubMed ID: 14503964
[TBL] [Abstract][Full Text] [Related]
40. Development and optimization of an adenovirus production process.
Kamen A; Henry O
J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
